Direct listing Announced
Lakewood-Amedex Biotherapeutics direct listing
NASDAQ: LABT
Advisers
Lead managers
Not disclosed
- Issuer
- Lakewood-Amedex Biotherapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- ADARx Pharmaceuticals IPO Sep 2026 · US$446m · Biotech
- ADARx Pharmaceuticals placement Sep 2026 · US$89m · Biotech
- Electra Therapeutics IPO Sep 2026 · US$350m · Biotech
- Amylyx Pharmaceuticals equity raising Aug 2026 · US$575m · Biotech
- AbCellera Biologics equity raising Aug 2026 · US$200m · Biotech
Sources
- 23 Apr 2026 Final IPO prospectus (424B4), Lakewood-Amedex Biotherapeutics Inc. sec.gov